Reports of animal studies and clinical trials indicate that among pro-inflammatory cytokines, IL-6 plays a unique role in the pathophysiology and somatic consequences of depression, and also mediate the effects of treatment of depressive disorder60,61. This evidence concerns the gene IL6 and depressive symptom measurement.